Heptaplatin
98%
- Product Code: 196208
CAS:
146665-77-2
| Molecular Weight: | 471.36 g./mol | Molecular Formula: | C₁₁H₂₀N₂O₆Pt |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00931412 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, avoid light, inert gas storage |
Product Description:
Used in cancer treatment, particularly for solid tumors such as non-small cell lung cancer and gastric cancer. Shows activity in patients who have developed resistance to other platinum-based drugs like cisplatin. Designed to have lower toxicity and better tolerability, especially reducing kidney damage and nausea. Administered intravenously in clinical settings as part of chemotherapy regimens. Currently under investigation in clinical trials to determine full efficacy and long-term safety profile.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿23,500.00 |
+
-
|
| 250mg | 10-20 days | ฿35,230.00 |
+
-
|
Heptaplatin
Used in cancer treatment, particularly for solid tumors such as non-small cell lung cancer and gastric cancer. Shows activity in patients who have developed resistance to other platinum-based drugs like cisplatin. Designed to have lower toxicity and better tolerability, especially reducing kidney damage and nausea. Administered intravenously in clinical settings as part of chemotherapy regimens. Currently under investigation in clinical trials to determine full efficacy and long-term safety profile.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :